Aerie Pharmaceuticals reported $-125712000 in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Aerie Pharmaceuticals AERI:US $ -125.71M 108.38M
Alimera Sciences ALIM:US $ -8.6M 6M
Amarin AMRN:US $ 641.11M 25.99M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Cara Therapeutics CARA:US $ 204.11M 23.41M
Coherus Biosciences CHRS:US $ 12.56M 85.16M
Endo International Ordinary Shares ENDP:US $ -1311M 67.01M
Horizon Pharma HZNP:US $ 4817.83M 145.44M
Insmed INSM:US $ 119.88M 290.59M
JAZZ PHA JAZZ:US $ 3608.49M 356.7M
Merk MRK:US $ 40883M 2699M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Novartis NOVN:VX SF 61540M 6115M
Ophthotech OPHT:US $ 333.15M 27.37M
Pacira Pharmaceuticals PCRX:US $ 709.58M 20.83M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Revance Therapeutics RVNC:US $ 25.54M 42.93M
Supernus Pharmaceuticals SUPN:US $ 828.45M 12.6M
Teva Pharmaceutical Industries TEVA:US $ 9344M 934M
Valeant Pharmaceuticals VRX:CN $ -216M 110M
Zoetis ZTS:US $ 4658M 115M